-
admin
Posts
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
NEW YORK, Aug. 6, 2024 /PRNewswire/ — Aquaron Acquisition Corp. (NASDAQ: AQU, the “Company“), a special purpose acquisition company, announced today that HUTURE Ltd. (“Huture“)...
Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company’s Next CEO
Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a...
Pet Beverage Packaging Market to Reach $47.8 Billion, Globally, by 2032 at 4.8% CAGR: Allied Market Research
The rising awareness related to environment pollution, stringent government regulations associated with plastic, and rapid boost in the beverages industry especially in the developing countries...
Celebrity Designer Nikki Chu Creates New Collection of Globally Inspired Tiles Exclusively for The Tile Shop
Chu’s debut tile designs are available now at tileshop.com and Tile Shop showrooms. MINNEAPOLIS, Aug. 05, 2024 (GLOBE NEWSWIRE) — Celebrity interior designer Nikki Chu’s...
Unlock Game-Changing Business Strategies at the Xcelerator Business Summit, October 3-4, 2024, in Naperville, IL
Naperville, Aug. 05, 2024 (GLOBE NEWSWIRE) — Naperville, Illinois – This fall, the Xcelerator Business Summit, scheduled for October 3-4, 2024 at The Matrix Club...
The Niche Research Report: Unleashing Potential with Breakthrough Innovations in Facial Injectables Market
Global Facial Injectables Market is Driven by Increasing Consumer Demand for Minimally Invasive Cosmetic Procedures that Offer Quick, Effective, and Natural-Looking Results Wilmington, Delaware, Aug....
Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting...
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
Company expects to commercialize the investigational ARC-EX® System in Q4 2024 and has commenced launch preparations Company preparing to initiate global pivotal trial for investigational...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products...
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024
New York, Aug. 05, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today...